BR9712705A - Composition for the treatment of asthma, containing loratadine and a decongestant - Google Patents

Composition for the treatment of asthma, containing loratadine and a decongestant

Info

Publication number
BR9712705A
BR9712705A BR9712705-1A BR9712705A BR9712705A BR 9712705 A BR9712705 A BR 9712705A BR 9712705 A BR9712705 A BR 9712705A BR 9712705 A BR9712705 A BR 9712705A
Authority
BR
Brazil
Prior art keywords
asthma
treatment
decongestant
composition
containing loratadine
Prior art date
Application number
BR9712705-1A
Other languages
Portuguese (pt)
Inventor
Alan G Harris
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of BR9712705A publication Critical patent/BR9712705A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Patente de Invenção:<B>"COMPOSIçãO PARA O TRATAMENTO DA ASMA, CONTENDO LORATADINA E UM DESCONGESTIONANTE"<D>. A invenção engloba um processo para aperfeiçoamento da função pulmonar de um paciente sofrendo de asma, compreendendo a aplicação ao paciente com rinite usual, de quantidades eficazes de loratidina para o tratamento e um descongestionante tal como pseudoefedrina.Invention Patent: <B> "COMPOSITION FOR THE TREATMENT OF ASTHMA, CONTAINING LORATADINE AND A DECONGESTIONING" <D>. The invention encompasses a process for improving the pulmonary function of a patient suffering from asthma, comprising the application to the patient with usual rhinitis, effective amounts of loratidine for treatment and a decongestant such as pseudoephedrine.

BR9712705-1A 1996-10-31 1997-10-29 Composition for the treatment of asthma, containing loratadine and a decongestant BR9712705A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73966996A 1996-10-31 1996-10-31
PCT/US1997/019158 WO1998018470A1 (en) 1996-10-31 1997-10-29 Composition, for the treatment of asthma, containing loratadine and a decongestant

Publications (1)

Publication Number Publication Date
BR9712705A true BR9712705A (en) 1999-10-26

Family

ID=24973307

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9712705-1A BR9712705A (en) 1996-10-31 1997-10-29 Composition for the treatment of asthma, containing loratadine and a decongestant

Country Status (21)

Country Link
EP (1) EP0941091A1 (en)
JP (1) JP2000505104A (en)
KR (1) KR20000052922A (en)
CN (1) CN1235545A (en)
AR (1) AR008908A1 (en)
AU (1) AU731756B2 (en)
BR (1) BR9712705A (en)
CA (1) CA2268546A1 (en)
CO (1) CO4910128A1 (en)
CZ (1) CZ150999A3 (en)
HU (1) HUP9904075A3 (en)
ID (1) ID23431A (en)
IL (1) IL129662A0 (en)
NO (1) NO992062D0 (en)
NZ (1) NZ335078A (en)
PE (1) PE11399A1 (en)
PL (1) PL333056A1 (en)
SK (1) SK54599A3 (en)
TR (1) TR199901003T2 (en)
WO (1) WO1998018470A1 (en)
ZA (1) ZA979731B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2307790A1 (en) * 1997-10-29 1999-05-06 J-Med Pharmaceuticals, Inc. Antihistamine/decongestant regimens for treating rhinitis
US6132758A (en) 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
IT1303671B1 (en) * 1998-07-28 2001-02-23 Nicox Sa SALTS OF NITRIC ACID WITH ACTIVE DRUGS IN THE TREATMENT OF DISEASES OF THE RESPIRATORY SYSTEM
CO5271713A1 (en) * 1998-09-10 2003-04-30 Schering Corp METHODS AND COMPOSITIONS TO TREAT SINUSITIS, MEDIUM OTITIS AND OTHER RELATED DISORDERS USING ANTIHISTAMINS
US6521254B2 (en) 1998-12-07 2003-02-18 J-Med Pharmaceuticals, Inc. Single-dose antihistamine/decongestant formulations for treating rhinitis
KR100505899B1 (en) * 1999-02-23 2005-08-01 주식회사유한양행 Pharmaceutical capsule compositions containing loratadine and pseudoephedrine
ATE253354T1 (en) * 1999-02-23 2003-11-15 Yuhan Corp CAPSULES WITH COMPOSITIONS CONTAINING LORATADINE AND PSEUDOEPHEDRINE
WO2000057880A1 (en) * 1999-03-29 2000-10-05 Schering Corporation Methods and compositions for treating allergic and related disorders using fluorinated descarboethoxyloratadine
SK287684B6 (en) * 1999-12-20 2011-06-06 Schering Corporation Sustained release solid oral pharmaceutical dosage composition
WO2001045676A2 (en) * 1999-12-20 2001-06-28 Schering Corporation Extended release oral dosage composition
EP1276502A1 (en) * 2000-04-14 2003-01-22 J-Med Pharmaceuticals, Inc. Single-dose antihistamine/decongestant formulations for treating rhinitis
WO2001089527A2 (en) * 2000-05-24 2001-11-29 Schering Corporation Pharmaceutical composition comprising loratadine and a nasal decongestant
CA2450583A1 (en) * 2001-06-20 2003-01-03 Schering Corporation Antihistamines for the treatment of nasal congestion and nasal obstruction
ES2398960T3 (en) 2005-06-17 2013-03-22 Aft Pharmaceuticals Limited Novel pharmaceutical composition and its use in a method for the treatment of patients with mucosal cangestion of the upper respiratory tract
NZ573174A (en) * 2006-06-01 2012-01-12 Msd Consumer Care Inc Sustained release pharmaceutical dosage form containing phenylephrine
RU2454225C2 (en) * 2006-06-01 2012-06-27 Эм Эс Ди Консьюмер Кэар, Инк. Pharmaceutical dosage forms and compositions of colon absorbed phenylephrine
KR101540191B1 (en) * 2014-02-24 2015-07-28 성균관대학교산학협력단 Composition comprising Loratadine for anti-inflammation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1110397A (en) * 1964-10-02 1968-04-18 Mead Johnson & Co Ephedrine composition
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
US5407686A (en) * 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
US5314697A (en) * 1992-10-23 1994-05-24 Schering Corporation Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
US5595997A (en) * 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine

Also Published As

Publication number Publication date
PL333056A1 (en) 1999-11-08
CZ150999A3 (en) 1999-10-13
CN1235545A (en) 1999-11-17
NO992062L (en) 1999-04-29
TR199901003T2 (en) 1999-07-21
NZ335078A (en) 2000-10-27
SK54599A3 (en) 2000-08-14
AR008908A1 (en) 2000-02-23
NO992062D0 (en) 1999-04-29
AU4995397A (en) 1998-05-22
IL129662A0 (en) 2000-02-29
ZA979731B (en) 1998-04-29
WO1998018470A1 (en) 1998-05-07
HUP9904075A3 (en) 2002-02-28
CA2268546A1 (en) 1998-05-07
PE11399A1 (en) 1999-02-09
HUP9904075A2 (en) 2000-05-28
EP0941091A1 (en) 1999-09-15
CO4910128A1 (en) 2000-04-24
AU731756B2 (en) 2001-04-05
KR20000052922A (en) 2000-08-25
JP2000505104A (en) 2000-04-25
ID23431A (en) 2000-04-20

Similar Documents

Publication Publication Date Title
BR9712705A (en) Composition for the treatment of asthma, containing loratadine and a decongestant
BRPI0109131B8 (en) dna, expression vector comprising the same, modified porcine factor viii, its production process and therapeutic composition comprising the same
BR0009480A (en) Polyurethane solutions with alkoxysilane structure units
BR9911666A (en) Pharmaceutical combination, use of the combination, process for treating an inflammatory disease in a person suffering from or susceptible to such disease, and pharmaceutical composition
ITMI941252A0 (en) CATALYTIC COMPOSITION AND PROCESS FOR THE ALKYLATION OF AROMATIC COMPOUNDS
BR9806145A (en) Process for selective derivatization of taxanes
IT1290846B1 (en) CATALYTIC COMPOSITION AND PROCESS FOR THE AKYLATION AND / OR TRANSALKYLATION OF AROMATIC COMPOUNDS
IL140118A0 (en) Use of optically pure (+) norcisapride for treating apnea, bulimia and other disorders
BR9809022A (en) Topical nasal anti-inflammatory compositions
BR9913072A (en) Azacyclic ring systems, pharmaceutical composition, and process to induce analgesia
BR9710390B1 (en) process for preparing silica compatible with flavorings, use of silica, and dentifrice composition.
BR9813996A (en) 2-arylbenzo [b] thiophenes useful for the treatment of estrogen deprivation syndrome
PE118999A1 (en) COMPOSITIONS AND METHODS FOR TREATING RESPIRATORY DISORDERS
BR9911917A (en) Compositions comprising gaba and caffeine analogs
WO2003035679A3 (en) Molecules
BR9914848A (en) Composition and process for the treatment of disorders of the external retina
DE69411726D1 (en) COMPOSITIONS FOR RELEASING AN AROMATIC SUBSTANCE INTO THE NOSE
CA2288650A1 (en) A method for the treatment of mental illness in mammals and a composition therefor
BR0103710A (en) Protection of keratin fibers using ceramides and / or glucoceramides
ATE309811T1 (en) ANALGESIC FROM SNAKE VENOM
BR0113650A (en) N- (3,5-dichloro-2-methoxyphenyl) -4-methoxy-3-piperazine-1-yl-benzenesulfonamide
BR9712767A (en) Expression specific for retinoblastoma protein tissue
NO982582L (en) Procedure for the treatment of pain
DK1071463T3 (en) Process and compositions using terfenadine metabolites in combination with leukotriene inhibitors
FI951759A0 (en) Process for the preparation of 2,2-difluorokethylsilyl-O, S-acetals and O, S-esters of alpha, alpha-difluoro-beta-silyloxy-1,3-dioxolane-4-propanoic acid

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal